HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists (CAP), American Society for Clinical Pathology (ASCP), and American Society of Clinical Oncology (ASCO)

View Publication
Download Tools & Resources
Standards Reporting Form
PROSPERO

Collection

MeSH Terms

Histological Techniques (E05.200.750); Standard of Care (N05.715.840); Quality Assurance; Health Care (N05.700); Quality of Health Care (N05.715); Antibodies; Monoclonal; Humanized (D12.776.124.486.485.114.224.060); Gastrointestinal Tract (A03.556); Adenocarcinoma (C04.557.470.200.025); Gastrointestinal Neoplasms (C04.588.274.476); Stomach Neoplasms (C04.588.274.476.767); Molecular Diagnostic Techniques (E05.200.880)

Keywords

her2, gastric, human epidermal growth factor receptor 2, clinical guideline, gastroesophageal, gea, cancer

Record Publish Year

2016

Publication Date

Original: November 14, 2016

Expected Publication Date

Update: Q4, 2025

Guideline Contact

Tanja Kalicanin (tkalica@cap.org)

Publication Scope

assessment

treatment

Countries of Application

United States

Guideline Publication Status

Under Review

Languages

English

Authors

CAP (US)

Publication Year

2016